Nesiritide Therapy to Preserve Function of the Left Ventricle After Myocardial Infarction

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

November 30, 2012

Study Completion Date

April 30, 2013

Conditions

Acute Myocardial Infarction

Interventions

DRUG

Nesiritide

Infusion of 72 hours of IV nesiritide at 0.006 mcg/kg/min.

DRUG

Placebo

Infusion of 72 hours of saline solution (packaged to match active comparator)

Trial Locations (2)

Mayo Clinic, Jacksonvilee

Mayo Clinic, Rochester